14-50312014-G-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_024884.3(L2HGDH):​c.137C>T​(p.Thr46Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000314 in 1,563,862 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T46T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 0 hom. )

Consequence

L2HGDH
NM_024884.3 missense

Scores

1
3
15

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.56

Publications

1 publications found
Variant links:
Genes affected
L2HGDH (HGNC:20499): (L-2-hydroxyglutarate dehydrogenase) This gene encodes L-2-hydroxyglutarate dehydrogenase, a FAD-dependent enzyme that oxidizes L-2-hydroxyglutarate to alpha-ketoglutarate in a variety of mammalian tissues. Mutations in this gene cause L-2-hydroxyglutaric aciduria, a rare autosomal recessive neurometabolic disorder resulting in moderate to severe cognitive disability. [provided by RefSeq, Jul 2008]
DMAC2L (HGNC:18799): (distal membrane arm assembly component 2 like) This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. This gene encodes the subunit s, also known as factor B, of the proton channel. This subunit is necessary for the energy transduction activity of the ATP synthase complexes. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0071794093).
BP6
Variant 14-50312014-G-A is Benign according to our data. Variant chr14-50312014-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 435697.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00141 (214/152306) while in subpopulation AFR AF = 0.00464 (193/41574). AF 95% confidence interval is 0.00411. There are 1 homozygotes in GnomAd4. There are 99 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
L2HGDHNM_024884.3 linkc.137C>T p.Thr46Ile missense_variant Exon 1 of 10 ENST00000267436.9 NP_079160.1 Q9H9P8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
L2HGDHENST00000267436.9 linkc.137C>T p.Thr46Ile missense_variant Exon 1 of 10 1 NM_024884.3 ENSP00000267436.4 Q9H9P8-1

Frequencies

GnomAD3 genomes
AF:
0.00141
AC:
214
AN:
152188
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00466
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.000387
AC:
64
AN:
165552
AF XY:
0.000310
show subpopulations
Gnomad AFR exome
AF:
0.00495
Gnomad AMR exome
AF:
0.000449
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000757
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000196
AC:
277
AN:
1411556
Hom.:
0
Cov.:
31
AF XY:
0.000185
AC XY:
129
AN XY:
698248
show subpopulations
African (AFR)
AF:
0.00560
AC:
182
AN:
32526
American (AMR)
AF:
0.000449
AC:
17
AN:
37832
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25312
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37394
South Asian (SAS)
AF:
0.0000124
AC:
1
AN:
80948
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45574
Middle Eastern (MID)
AF:
0.00197
AC:
9
AN:
4568
European-Non Finnish (NFE)
AF:
0.0000321
AC:
35
AN:
1088872
Other (OTH)
AF:
0.000564
AC:
33
AN:
58530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00141
AC:
214
AN:
152306
Hom.:
1
Cov.:
32
AF XY:
0.00133
AC XY:
99
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00464
AC:
193
AN:
41574
American (AMR)
AF:
0.000784
AC:
12
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68018
Other (OTH)
AF:
0.00284
AC:
6
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000629
Hom.:
1
Bravo
AF:
0.00165
ESP6500AA
AF:
0.00264
AC:
11
ESP6500EA
AF:
0.000122
AC:
1
ExAC
AF:
0.000435
AC:
51
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 10, 2018
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

L-2-hydroxyglutaric aciduria Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

L2HGDH-related disorder Benign:1
Dec 02, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
17
DANN
Benign
0.93
DEOGEN2
Benign
0.023
T;T;T;.;T
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.57
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.84
T;.;T;T;T
M_CAP
Pathogenic
0.40
D
MetaRNN
Benign
0.0072
T;T;T;T;T
MetaSVM
Uncertain
-0.16
T
MutationAssessor
Benign
0.69
.;N;N;.;.
PhyloP100
1.6
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.8
N;N;N;N;N
REVEL
Benign
0.17
Sift
Benign
0.11
T;T;T;T;T
Sift4G
Benign
0.16
T;T;T;T;T
Polyphen
0.0080
B;B;B;.;.
Vest4
0.40
MVP
0.70
MPC
0.23
ClinPred
0.020
T
GERP RS
2.6
PromoterAI
0.079
Neutral
Varity_R
0.077
gMVP
0.26
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201806251; hg19: chr14-50778732; API